HONG KONG — A new technology promises to deliver levodopa at more constant levels over time. It depends on a folded, accordion-like structure inside a gelatin capsule. When swallowed, the capsule ...

Amneal Pharmaceuticals has announced positive topline results from the phase 3 RISE-PD trial evaluating a novel formulation of carbidopa/levodopa for patients with Parkinson’s disease (PD) who have ...

Levodopa—the gold-standard treatment for Parkinson's disease—increases dopamine in the brain. But as the disease progresses in severity, patients often need to take additional drugs to manage their ...

Medications for Parkinson’s may help replenish dopamine levels or mimic its effects, addressing the deterioration of brain cells that produce this neurotransmitter. Carbidopa-levodopa is commonly the ...

If you have Parkinson’s disease, you’ve probably heard of levodopa (Parcopa, Sinemet). It’s the most common medicine to control Parkinson’s symptoms, although there are many others that treat the ...

There have been many remarkable changes in treatments for Parkinson's disease in recent years. Scientists have developed new drugs, and they have a better understanding of how to use older treatments.

Acorda Therapeutics ($ACOR) moved a step closer to collecting the payoff from its $525 million acquisition of Civitas, maker of an inhaled levodopa, in the scramble ...

A study from Emory University suggests that levodopa, a medication that increases dopamine levels in the brain, may help treat individuals with depression who experience motivational impairments due ...